Nanobody-Based Probes for Subcellular Protein Identification and Visualization

Abstract

Understanding how building blocks of life contribute to physiology is greatly aided by protein identification and cellular localization. The two main labeling approaches developed over the past decades are labeling with antibodies such as immunoglobulin G (IgGs) or use of genetically encoded tags such as fluorescent proteins. However, IgGs are large proteins (150 kDa), which limits penetration depth and uncertainty of target position caused by up to ∼25 nm distance of the label created by the chosen targeting approach. Additionally, IgGs cannot be easily recombinantly modulated and engineered as part of fusion proteins because they consist of multiple independent translated chains. In the last decade single domain antigen binding proteins are being explored in bioscience as a tool in revealing molecular identity and localization to overcome limitations by IgGs. These nanobodies have several potential benefits over routine applications. Because of their small size (15 kDa), nanobodies better penetrate during labeling procedures and improve resolution. Moreover, nanobodies cDNA can easily be fused with other cDNA. Multidomain proteins can thus be easily engineered consisting of domains for targeting (nanobodies) and visualization by fluorescence microscopy (fluorescent proteins) or electron microscopy (based on certain enzymes). Additional modules for e.g., purification are also easily added. These nanobody-based probes can be applied in cells for live-cell endogenous protein detection or may be purified prior to use on molecules, cells or tissues. Here, we present the current state of nanobodybased probes and their implementation in microscopy, including pitfalls and potential future opportunities.

In vivo proximity biotin ligation identifies the interactome of Egalitarian, a Dynein cargo adaptor

“…However, given that we were in possession of a strain in which dTtc1 was tagged with GFP, we decided to develop a nanoboby based approach. A nanobody is a small protein, usually 15kD or less, that consists of the antigen-recognition domain of a single chain antibody (de Beer and Giepmans, 2020). We fused the GFP nanobody, referred to as the GFP binding protein (GBP), to Trbo.…”

Ovary Development: Insights From a Three-Dimensional Imaging Revolution

“…To increase labeling efficiency and enhance subcellular protein identification in aged ovaries, recently developed probes and fluorophores provide promising alternatives to conventional immunoglobulin G (IgG) antibodies. Nanobodies are monomeric (heavy chain only) antibody fragments with the advantages of small size (15 kDa compared to 150 kDa for IgGs) allowing deeper and more effective penetration into tissue, higher binding affinity for their targets, and increased fluorescence intensity, thus providing better visualization of samples ( de Beer and Giepmans, 2020 ). A nanobody based approach, along with an improved clearing protocol, was implemented in whole-body immunolabeling and visualization of mice, enabling Cai et al (2019) to map neuronal projections in adult mice, and simultaneously to uncover short vascular connections in the brain which had previously not been visualized.…”

New Methodologies to Study DNA Repair Processes in Space and Time Within Living Cells

“…However, this results in protein overexpression which can create an imbalance between the different actors of the DDR, potentially leading to artifacts. To overcome this problem, the tagging of the endogenous protein can be achieved by CRISPR/Cas9 based genome editing ( Stewart-Ornstein and Lahav, 2016 ) or via the use of fluorescently labeled nanobodies raised against the repair proteins of interest ( Buchfellner et al, 2016 ; de Beer and Giepmans, 2020 ). Importantly, the association between the nanobody and its target must be tight enough to ensure that the dynamics of the fluorescence distribution adequately represents the one of the repair protein, but it should also have no impact the function of this protein ( Buchfellner et al, 2016 ).…”